Need Help?

Whole genome sequence of Primary-recurrent HCC study

This dataset contains whole genome sequence data from 24 samples, including 16 tumors and 8 normal samples. All the experiments were performed on Illumina HiSeq 2000 platform with raw reads stored in fastq format.

Request Access

Data Assess policy for CUHK liver cancer project

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Nathalie Wong grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Nathalie Wong and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. The Chinese University of Hong Kong: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Nathalie Wong within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Nathalie Wong prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Nathalie Wong as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Nathalie Wong may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Nathalie Wong. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. Applicants should ask for Appendix I,II, III by email.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001002094 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00001393192 fastq.gz 103.7 GB
EGAF00001393193 fastq.gz 104.6 GB
EGAF00001393194 fastq.gz 134.3 GB
EGAF00001393195 fastq.gz 134.9 GB
EGAF00001393196 fastq.gz 81.0 GB
EGAF00001393197 fastq.gz 81.3 GB
EGAF00001393198 fastq.gz 79.0 GB
EGAF00001393199 fastq.gz 80.0 GB
EGAF00001393200 fastq.gz 148.8 GB
EGAF00001393201 fastq.gz 150.4 GB
EGAF00001393202 fastq.gz 85.8 GB
EGAF00001393203 fastq.gz 86.8 GB
EGAF00001393204 fastq.gz 87.2 GB
EGAF00001393205 fastq.gz 88.3 GB
EGAF00001393206 fastq.gz 133.8 GB
EGAF00001393207 fastq.gz 136.2 GB
EGAF00001393208 fastq.gz 90.5 GB
EGAF00001393209 fastq.gz 91.2 GB
EGAF00001393210 fastq.gz 83.2 GB
EGAF00001393211 fastq.gz 83.8 GB
EGAF00001393212 fastq.gz 138.1 GB
EGAF00001393213 fastq.gz 140.7 GB
EGAF00001393214 fastq.gz 90.0 GB
EGAF00001393215 fastq.gz 91.0 GB
EGAF00001393216 fastq.gz 79.0 GB
EGAF00001393217 fastq.gz 79.5 GB
EGAF00001393218 fastq.gz 140.8 GB
EGAF00001393219 fastq.gz 141.9 GB
EGAF00001393220 fastq.gz 87.8 GB
EGAF00001393221 fastq.gz 88.2 GB
EGAF00001393222 fastq.gz 80.5 GB
EGAF00001393223 fastq.gz 81.0 GB
EGAF00001393224 fastq.gz 131.5 GB
EGAF00001393225 fastq.gz 133.0 GB
EGAF00001393226 fastq.gz 80.7 GB
EGAF00001393227 fastq.gz 81.5 GB
EGAF00001393228 fastq.gz 83.0 GB
EGAF00001393229 fastq.gz 83.5 GB
EGAF00001393230 fastq.gz 130.9 GB
EGAF00001393231 fastq.gz 132.0 GB
EGAF00001393232 fastq.gz 86.9 GB
EGAF00001393233 fastq.gz 87.8 GB
EGAF00001393234 fastq.gz 82.1 GB
EGAF00001393235 fastq.gz 82.6 GB
EGAF00001393236 fastq.gz 132.2 GB
EGAF00001393237 fastq.gz 133.4 GB
EGAF00001393238 fastq.gz 86.1 GB
EGAF00001393239 fastq.gz 86.9 GB
48 Files (4.9 TB)